Abnormal progesterone and corticotropin releasing hormone levels are associated with preterm labour

Annals of the Academy of Medicine Singapore

Volumn 38, Issue 11, 2009, Pages 1011-1016

  Stamatelou, Foteini ^a   Deligeoroglou, Efthimios ^b   Farmakides, Georgios ^a   Creatsas, Georgios ^b  

^a HELENA VENIZELOU HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Biochemical markers; Gestation; Hormones; Prematurity

Indexed keywords

BIOCHEMICAL MARKER; CORTICOTROPIN RELEASING FACTOR; PROGESTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; DELIVERY; FEMALE; FOLLOW UP; GESTATIONAL AGE; HORMONE BLOOD LEVEL; HUMAN; LABOR; MATERNAL PLASMA; OBSERVATIONAL METHOD; PREMATURE LABOR; PROGESTERONE BLOOD LEVEL; PROSPECTIVE STUDY; PUERPERIUM; RADIOIMMUNOASSAY; RISK FACTOR; THIRD TRIMESTER PREGNANCY;

EID: 73249132924     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Challis JR. CRH a placental clock and preterm labor. Nat Med 1995;1:416.
2. Leviton LC, Goldenburgh RL, Baker CS, Swartz RM, Freda MC, Fish LJ, et al. Methods to encourage the use of antenatal corticosteroid therapy for fetal maturation: a randomized controlled trial. JAMA 1999;281:46-52.
3. Keller PA, Kirkwood K, Morgan J, Westcott S, McCluskey A. The prevention of preterm labour-corticotrophin releasing hormone type 1 receptors as a target for drug design and development. Mini reviews in Medicinal Chemistry 2003;3:295-303.
4. Iams J. Prevention of preterm labor. N Engl J Med 1998;338:54-6.
5. Caritis SN. Treatment of preterm labour. A review of the therapeutic options. Drugs 1983;26:243-61.
6. Zarutskie PW and Phillips JA. Reanalysis of vaginal progesterone as luteal phase support in assisted reproduction cycles. Fertil Steril 2007;88:S113.
7. Loose DS and Stancel GM. Estrogens and Progestins. In: Brunton LL. Lazo JS, Parker KL, editors. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 11th ed. New York: McGraw-Hill, 2006.
8. Fiala C, Gemzel-Danielsson K. Review of medical abortion using mifepristone in combination with a prostaglandin analogue. Contraception 2006;74:66-86.
9. Da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: A randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003;188:419-24.
10. Gibb W, Challis JR. Mechanisms of term and preterm birth. J Obstet Gynaecol Can 2002;24:874-83.
11. Karalis K, Majzoub JA. Regulation of placental corticotrophin releasing hormone by steroids: possible implication in labour initiation. Ann NY Acad Sci 1995;771:551-5.
12. Darne J, McGarrigle HH, Lachelin GC. Increased saliva oestriol to progesterone ratio before preterm delivery: a possible predictor for preterm labour? Br Med J (Clin Res Ed) 1987;294:270-2.
13. Mesiano S. Myometrial progesterone responsiveness and the control of human parturition. J Soc Gynecol Investig 2004;11:193-202.
14. Meis PJ, Klebanoff M, Thom E Dombroniski MP, Sibai B, Mouwad AH, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003;348:2379-85.
15. Mackenzie R, Walker M, Armson A, Hannah ME. Progesterone for the prevention of preterm birth among women at increased risk: A systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol 2006;194:1234-42.